Short-Term Visiting Fellowship In Crispr Cas Technology In Italy Lazio

Short-Term Visiting Fellowship In Crispr Cas Technology In Italy
Roma
Lazio, Lazio

Prof. Donato Zipeto at the University of Verona, Italy, invites scientists and physician-scientists around the world for a short-term certified fellowship in CRISPR/Cas9 Gene Editing Technology.

Please refer your colleagues or interested students.

This program is only available through Trialect's seizfire platform.

Career Benefits of CRISPR/Cas Technology Leadership in Genetic Engineering Pharmaceutical Innovation and Collaboration Potential for Groundbreaking Discoveries Career Advancement in Pharma: Amgen, Novartis, Gilead Sciences, Merck, and Pfizer are all active in this area.

Feedback The training period, 2 weeks, was too short to accommodate all its components.

It was a live, hands-on experience, and the group members in the hosting Lab helped me during the hands-on training.

They were dedicated and willingly transferred all their skills to me within a limited period.

Thanks a lot to the group.

#J-18808-Ljbffr